A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
Clinical trial NCT05050136 · RECRUITING
Trial details
- NCT number
- NCT05050136
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-22
- Primary completion
- 2027-04-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.